Rexford Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Rexford Capital's BMY Position: Q2 2026 in Review
Rexford Capital held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 6,206 shares worth $358K. The position accounts for 0.22% of the portfolio, ranked #117.
Rexford Capital first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $376K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Rexford Capital held 6,206 shares of Bristol-Myers Squibb worth $358K as of Q2 2026.
- Rexford Capital left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.22% of Rexford Capital's portfolio in Q2 2026, its #117 holding.
- Rexford Capital first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
- Rexford Capital's Bristol-Myers Squibb position peaked at $376K in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Rexford Capital's 13F filing for Q2 2026, filed 29 Jul 2026.